You are here: Industry Insights > Rentschler

News List

Rentschler Biopharma Breaks Ground at U.S. Site Near Boston contractpharma
August 13, 2021
New facility to significantly expand cGMP manufacturing capacity for clinical and commercial supply of biopharmaceuticals.
Rentschler Expands Complex Antibodies Production in Germany contractpharma
July 01, 2021
Rentschler Biopharma is in the process of expanding its 2,000-liter bioreactor production capacity at its site in Germany.
Vetter, Rentschler Biopharma Advance Strategic Alliance contractpharma
April 29, 2021
Rentschler Biopharma and Vetter, two global CDMOs, have advanced their strategic collaboration, establishing a framework for their alliance and set up a governance structure, as well as implemented guidelines for their joint approach across functions.
Rentschler Biopharma Names Martin Kessler as New CEO in U.S. contractpharma
April 01, 2021
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, has appointed of Dr. Martin Kessler as CEO of Rentschler Biopharma Inc., the company’s wholly owned U.S. subsidiary, and as ...
Rentschler, Leukocare Extend Service Offering with U.S. Site contractpharma
March 23, 2021
Opens Leukocare’s U.S. development labs and offices at Rentschler's facility in the Greater Boston area, where the two companies will work together.
Rentschler Biopharma to build cell and gene therapy manufacturing capabilities in the UK pharmatimes
February 24, 2021
Rentschler Biopharma, a German contract development and manufacturing organisation (CDMO), will build new cell and gene therapy capabilities at a Cell and Gene Therapy (CGT) Catapult site in Stevenage, UK.
CureVac & Rentschler Biopharma Collaborate on Vaccine contractpharma
February 09, 2021
CureVac N.V., a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA), and Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for ...
CureVac, Rentschler Ramp up COVID Vax Production contractpharma
February 02, 2021
CureVac N.V. and Rentschler Biopharma SE, a global CDMO for biopharmaceuticals, initiated the set-up of manufacturing capabilities for CureVac´s COVID-19 vaccine, CVnCoV.
Rentschler, Horizon Ink Cell Line Development Pact contractpharma
May 20, 2020
The alliance aims to drive efficiencies in biotherapeutic manufacturing from early drug development through commercial manufacturing.
Rentschler Biopharma Takes on New Projects at Milford, MA Facility contractpharma
September 05, 2019
The site will support both clinical and commercial manufacturing programs .

Previous page 1 2 Next page